Commonwealth Equity Services LLC Sells 4,479 Shares of InMode Ltd. (NASDAQ:INMD)

Commonwealth Equity Services LLC reduced its stake in shares of InMode Ltd. (NASDAQ:INMD) by 9.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,014 shares of the healthcare company’s stock after selling 4,479 shares during the quarter. Commonwealth Equity Services LLC owned about 0.06% of InMode worth $752,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of INMD. State Street Corp boosted its stake in shares of InMode by 3.7% during the 3rd quarter. State Street Corp now owns 2,044,640 shares of the healthcare company’s stock worth $34,657,000 after purchasing an additional 73,183 shares during the period. Geode Capital Management LLC boosted its position in shares of InMode by 0.6% during the third quarter. Geode Capital Management LLC now owns 1,101,951 shares of the healthcare company’s stock valued at $18,678,000 after buying an additional 6,282 shares during the period. Systematic Financial Management LP boosted its position in shares of InMode by 13.3% during the third quarter. Systematic Financial Management LP now owns 982,111 shares of the healthcare company’s stock valued at $16,647,000 after buying an additional 115,492 shares during the period. Disciplined Growth Investors Inc. MN grew its stake in shares of InMode by 0.4% during the third quarter. Disciplined Growth Investors Inc. MN now owns 808,149 shares of the healthcare company’s stock valued at $13,698,000 after buying an additional 3,191 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its holdings in shares of InMode by 12.9% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 720,750 shares of the healthcare company’s stock worth $12,217,000 after buying an additional 82,100 shares during the period. 68.04% of the stock is owned by institutional investors.

InMode Stock Down 0.7 %

INMD opened at $17.98 on Thursday. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $20.98. The company has a market capitalization of $1.25 billion, a P/E ratio of 7.65 and a beta of 2.08. The stock’s fifty day moving average is $18.38 and its two-hundred day moving average is $17.80.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on INMD. Barclays boosted their price objective on InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a report on Wednesday, February 5th. Needham & Company LLC reissued a “hold” rating on shares of InMode in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $22.25.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.